id: metformin_treatment_to_peripheral_nerve_preservation
name: Metformin Treatment â†’ Peripheral Nerve Preservation (IENFD)
from_node:
  node_id: metformin_treatment
  node_name: Metformin Treatment
to_node:
  node_id: peripheral_nerve_preservation
  node_name: Peripheral Nerve Preservation (IENFD)
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Metformin administration in diabetic conditions modulates metabolic pathways
  affecting nerve tissue'
- 'Step 2: Preserved intraepidermal nerve fiber density (IENFD) compared to untreated
  diabetes'
- 'Step 3: Structural preservation of nerve fibers prevents progression of diabetic
  peripheral neuropathy'
- 'Step 4: Improved sensory thresholds to mechanical and heat stimuli'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: S. Kim et al. 2020. "Metformin Preserves Peripheral Nerve Damage
    with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced
    Diabetic Rats." *Diabetes & Metabolism Journal*. https://doi.org/10.4093/dmj.2019.0190
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.248673'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: diabetes_severity
  direction: weakens
  strength: moderate
  description: Effects measured in STZ/HFD-induced diabetic model; baseline diabetic
    condition moderates neuroprotective effect
- name: treatment_duration
  direction: strengthens
  strength: moderate
  description: 24-week treatment duration showed maintained protective effects compared
    to 12-week assessment
